# Bridgewater Bancshares Inc: financial statements, quarterly

BWB · Nasdaq · CIK 1341317 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bwb.md) · [Financials](/companies/bwb/financials.md) · [Filings](/companies/bwb/filings.md) · [Insiders](/companies/bwb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bwb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [33.2 d](/filings/0001558370-24-002663.md) | [34.0](/filings/0001558370-24-006454.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.4 d](/filings/0001104659-26-020063.md) | [2.4](/filings/0001558370-25-006048.md) | [2.5](/filings/0001558370-25-009841.md) | [2.7](/filings/0001104659-25-104003.md) | [2.3 d](/filings/0001104659-26-020063.md) | [3.0](/filings/0001104659-26-052124.md) | [3.6](/filings/0001104659-26-088454.md) | [3.5](/filings/0001104659-26-119855.md) | [3.8 d](/filings/0001104659-26-020063.md) | [5.4](/filings/0001104659-26-052124.md) | [4.4](/filings/0001104659-26-088454.md) | [4.1](/filings/0001104659-26-119855.md) |
| Net income | $m | [8.9 d](/filings/0001104659-26-020063.md) | [7.8](/filings/0001558370-25-006048.md) | [8.1](/filings/0001558370-25-009841.md) | [8.7](/filings/0001104659-25-104003.md) | [8.2 d](/filings/0001104659-26-020063.md) | [9.6](/filings/0001104659-26-052124.md) | [11.5](/filings/0001104659-26-088454.md) | [11.6](/filings/0001104659-26-119855.md) | [13.3 d](/filings/0001104659-26-020063.md) | [17.4](/filings/0001104659-26-052124.md) | [14.0](/filings/0001104659-26-088454.md) | [15.0](/filings/0001104659-26-119855.md) |
| Diluted EPS | $ per share | not reported | [0.24](/filings/0001558370-25-006048.md) | [0.26](/filings/0001558370-25-009841.md) | [0.27](/filings/0001104659-25-104003.md) | not reported | [0.31](/filings/0001104659-26-052124.md) | [0.38](/filings/0001104659-26-088454.md) | [0.38](/filings/0001104659-26-119855.md) | not reported | [0.58](/filings/0001104659-26-052124.md) | [0.45](/filings/0001104659-26-088454.md) | [0.49](/filings/0001104659-26-119855.md) |
| Basic EPS | $ per share | not reported | [0.25](/filings/0001558370-25-006048.md) | [0.26](/filings/0001558370-25-009841.md) | [0.28](/filings/0001104659-25-104003.md) | not reported | [0.31](/filings/0001104659-26-052124.md) | [0.38](/filings/0001104659-26-088454.md) | [0.38](/filings/0001104659-26-119855.md) | not reported | [0.59](/filings/0001104659-26-052124.md) | [0.47](/filings/0001104659-26-088454.md) | [0.50](/filings/0001104659-26-119855.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [129](/filings/0001558370-25-002317.md) | [143](/filings/0001558370-24-006454.md) | [134](/filings/0001558370-24-010523.md) | [192](/filings/0001558370-24-014002.md) | [230](/filings/0001104659-26-020063.md) | [166](/filings/0001558370-25-006048.md) | [217](/filings/0001558370-25-009841.md) | [132](/filings/0001104659-25-104003.md) | [124](/filings/0001104659-26-119855.md) | [222](/filings/0001104659-26-052124.md) | [170](/filings/0001104659-26-088454.md) | [263](/filings/0001104659-26-119855.md) |
| Total assets | $m | [4,612](/filings/0001558370-25-002317.md) | [4,723](/filings/0001558370-24-006454.md) | [4,687](/filings/0001558370-24-010523.md) | [4,692](/filings/0001558370-24-014002.md) | [5,066](/filings/0001104659-26-020063.md) | [5,137](/filings/0001558370-25-006048.md) | [5,297](/filings/0001558370-25-009841.md) | [5,360](/filings/0001104659-25-104003.md) | [5,407](/filings/0001104659-26-119855.md) | [5,335](/filings/0001104659-26-052124.md) | [5,390](/filings/0001104659-26-088454.md) | [5,615](/filings/0001104659-26-119855.md) |
| Total liabilities | $m | [4,186](/filings/0001558370-25-002317.md) | [4,289](/filings/0001558370-24-006454.md) | [4,248](/filings/0001558370-24-010523.md) | [4,239](/filings/0001558370-24-014002.md) | [4,608](/filings/0001104659-26-020063.md) | [4,668](/filings/0001558370-25-006048.md) | [4,820](/filings/0001558370-25-009841.md) | [4,863](/filings/0001104659-25-104003.md) | [4,890](/filings/0001104659-26-119855.md) | [4,807](/filings/0001104659-26-052124.md) | [4,842](/filings/0001104659-26-088454.md) | [5,074](/filings/0001104659-26-119855.md) |
| Shareholders' equity | $m | [426](/filings/0001104659-26-020063.md) | [434](/filings/0001558370-25-009841.md) | [439](/filings/0001104659-25-104003.md) | [452](/filings/0001104659-25-104003.md) | [458](/filings/0001104659-26-119855.md) | [469](/filings/0001104659-26-088454.md) | [476](/filings/0001104659-26-119855.md) | [497](/filings/0001104659-26-119855.md) | [517](/filings/0001104659-26-119855.md) | [528](/filings/0001104659-26-088454.md) | [548](/filings/0001104659-26-119855.md) | [541](/filings/0001104659-26-119855.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.5) d](/filings/0001104659-26-020063.md) | [7.2](/filings/0001558370-25-006048.md) | [10.6 d](/filings/0001558370-25-009841.md) | [(6.0) d](/filings/0001104659-25-104003.md) | [34.6 d](/filings/0001104659-26-020063.md) | [7.1](/filings/0001104659-26-052124.md) | [3.6 d](/filings/0001104659-26-088454.md) | [10.1 d](/filings/0001104659-26-119855.md) | [7.0 d](/filings/0001104659-26-020063.md) | [16.0](/filings/0001104659-26-052124.md) | [10.0 d](/filings/0001104659-26-088454.md) | [46.0 d](/filings/0001104659-26-119855.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001104659-26-020063.md) | [0.0](/filings/0001558370-25-006048.md) | [0.2 d](/filings/0001558370-25-009841.md) | [0.5 d](/filings/0001104659-25-104003.md) | [3.4 d](/filings/0001104659-26-020063.md) | [0.5](/filings/0001104659-26-052124.md) | [1.2 d](/filings/0001104659-26-088454.md) | [1.6 d](/filings/0001104659-26-119855.md) | [2.5 d](/filings/0001104659-26-020063.md) | [1.8](/filings/0001104659-26-052124.md) | [0.6 d](/filings/0001104659-26-088454.md) | [0.4 d](/filings/0001104659-26-119855.md) |
| Share repurchases | $m | not reported | [2.3](/filings/0001558370-25-006048.md) | [2.9 d](/filings/0001558370-25-009841.md) | [0.0 d](/filings/0001104659-25-104003.md) | [0.0 d](/filings/0001104659-26-020063.md) | [0.6](/filings/0001104659-26-052124.md) | [1.6 d](/filings/0001104659-26-088454.md) | [0.0 d](/filings/0001104659-26-119855.md) | [0.0 d](/filings/0001104659-26-020063.md) | not reported | not reported | [0.0 d](/filings/0001104659-26-119855.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.5](/filings/0001558370-24-006454.md) | [28.2](/filings/0001558370-24-010523.md) | [28.3](/filings/0001558370-24-014002.md) | [28.1](/filings/0001558370-25-006048.md) | [27.7](/filings/0001558370-25-009841.md) | [27.9](/filings/0001104659-25-104003.md) | [28.0](/filings/0001104659-26-052124.md) | [28.0](/filings/0001104659-26-088454.md) | [28.2](/filings/0001104659-26-119855.md) | [28.5](/filings/0001104659-26-052124.md) | [28.6](/filings/0001104659-26-088454.md) | [28.8](/filings/0001104659-26-119855.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,014,252 at 2026-10-27, from the cover of the [10-Q filed 2026-10-29](/filings/0001104659-26-119855.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 14:43 ET. No prices; not investment advice.